跳至主要内容
临床试验/NCT04179994
NCT04179994Unknown不适用

Comparison of Clinical Efficacy of a Miswak Extract-Containing Toothpaste to a Dentifrice Containing Potassium Nitrate and to a Placebo on Dentinal Hypersensitivity: A Randomized Clinical Trial

Ministry of Health, Saudi Arabia0 个研究点目标入组 96 人开始时间: 2020年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
96
主要终点
Pain reduction

研究概览

简要总结

The study will be a single-center, longitudinal, triple-masked (for participants, operators, and statistician), equal ratio, randomized non-crossover design. The study designed following the criteria described by Holland et al 1997. The current experiments will follow CONSORT guidelines and will be registered at the US National Institutes of Health (ClinicalTrials.gov). The sensitivity scores will be measured at three intervals: at baseline, at 2 weeks, and at 6 weeks. The duration of the current study estimated to be 6 weeks and will be conducted between January 2020 and March 2020. The study protocol will be submitted initially to the Ethical Committee of the Aseer Central Hospital, Aseer region, Saudi Arabia. After getting the approval and facilitation letters, the participants will be selected randomly from patients attending periodontal clinics at Aseer Dental Center, Aseer region.

详细描述

Three toothpastes will be investigated during the study period that are 1) commercially available miswak extract-containing toothpaste; 2) commercially available toothpaste containing 5% potassium nitrate as positive control; 3) a toothpaste containing the same formulation as miswak extract except for the active ingredient (miswak extract) as negative control. Toothpastes will be dispensed in labeled containers named A,B, and C to achieve the triple masking for investigators, participants, and statisticians. Masked toothpastes will be revealed to the investigators after the statistical analyses.

After allocation, all subjects will be instructed to refrain from using any desensitizing agents for two weeks prior to the study up to the end of study period. The randomization process will be made using SPSS, the function "RAND" to assign every subject to random A, B, or C masked toothpastes. Moreover, to insure the blinded process of the study we will dispense the toothpastes in a previously prepared similar containers in separate area. Two trained examiners will read and record the scores each visit (baseline, 2-weeks, and 6-weeks). For the seek of examiners' calibration, Kappa statistic will be used to assess the inter-rater reproducibility and we will duplicate a 10% of the study results.

During each visit, teeth around the targeted tooth will be isolated with cotton rolls then the stimuli will be applied using a sharp dental explorer. It will be passed across the facial area of the tooth, perpendicular to the tooth long axis. The average of three consecutive applications will be recorded as a the reading for that tooth.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
20 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subjects with history of DH caused by cervical erosion or gingival recession
  • •Subjects show good general health
  • •Must have at least two teeth with VAS score of 4 or more

排除标准

  • •Subjects have teeth with caries, occlusal restorations, or orthodontic appliances
  • •Subjects allergic to ingredients used in the study
  • •Subjects present any oral pathology, eating disorders, chronic disease, or any disease requiring repeated or regular analgesia, anti-inflammatory drugs, or antihistamines

研究组 & 干预措施

Miswak extract-containing toothpaste group

Experimental

Test group.

干预措施: Miswak extract-containing toothpaste (Other)

Toothpaste containing Potassium Nitrates

Active Comparator

Positive control.

干预措施: Potassium nitrates-containing toothpaste (Other)

Placebo group

Placebo Comparator

Toothpaste contains same ingredients of test group except for the active ingredient as negative control.

干预措施: Placebo (Other)

结局指标

主要结局

Pain reduction

时间窗: 6 weeks period

Visual Analog Scale (VAS) will be used to measure pain intensity. The scale is graded from 1 to 10 with zero score indicates a pain-free response and 10 indicates sever pain or discomfort.

次要结局

未报告次要终点

研究者

发起方
Ministry of Health, Saudi Arabia
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Abdulrahman Alshehri

Principal Investigator

Ministry of Health, Saudi Arabia

相似试验